Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 85509-1920

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 85509-1920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine Hydrochloride Extended-release 15mg Capsules (8550919203)

This is a description of an extended-release capsule containing 15 mg of cyclobenzaprine hydrochloride, a medication used to treat muscle spasms. The recommended dosage for adults is 1 or 2 capsules daily at the same time. It is important to keep this medication out of reach of children and store it at a temperature range of 20°-25°C (68°-77°F). For more information, the package insert QR code can be scanned. The medication is dispensed in a light-resistant container and the NDC number and GTIN are provided for identification purposes. The product is made by Adare Pharmaceuticals, Inc., and repackaged by PHOENIX RX LLC in Hatboro, PA, USA. Rx only.*

FDA Label Image

Structural Formula (Image 1)

Not available.*

FDA Label Image

Image (Image 2)

FDA Label Image

Image (Image 3)

FDA Label Image

Image (Image 4)

FDA Label Image

Image (Image 5)

FDA Label Image

Image (Image 6)

FDA Label Image

Image (Image 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.